|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_ocn276434980 |
003 |
OCoLC |
005 |
20231117015134.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
081126s1969 nyua ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d IDEBK
|d E7B
|d OCLCQ
|d OPELS
|d OCLCQ
|d OCLCF
|d YDXCP
|d OCLCQ
|d LEAUB
|d UAB
|d OCLCO
|d OCLCQ
|d OCLCA
|d VLY
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 646756595
|a 907195427
|a 1162030888
|a 1397472542
|
020 |
|
|
|a 9780080580982
|q (electronic bk.)
|
020 |
|
|
|a 008058098X
|q (electronic bk.)
|
020 |
|
|
|a 0120329077
|q (electronic bk.)
|
020 |
|
|
|a 9780120329076
|q (electronic bk.)
|
020 |
|
|
|a 1281712221
|
020 |
|
|
|a 9781281712226
|
020 |
|
|
|a 9786611712228
|
020 |
|
|
|a 6611712224
|
035 |
|
|
|a (OCoLC)276434980
|z (OCoLC)646756595
|z (OCoLC)907195427
|z (OCoLC)1162030888
|z (OCoLC)1397472542
|
050 |
|
4 |
|a RM300
|b .A38eb vol. 7
|
072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
082 |
0 |
4 |
|a 615/.1
|2 22
|
245 |
0 |
0 |
|a Advances in pharmacology and chemotherapy.
|n Volume 7 /
|c edited by Silvio Garattini [and others].
|
260 |
|
|
|a New York :
|b Academic Press,
|c �1969.
|
300 |
|
|
|a 1 online resource (439 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Advances in pharmacology and chemotherapy ;
|v v. 7
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Advances in Pharmacology and Chemotherapy, Volume 7; Copyright Page; Contents; Contributors to This Volume; Foreword; Preface; Chapter 1. Recent Progress in Pharmacogenetics; I. History; II. Definitions; III. Types of Response to Drugs; IV. Genetic Control of Drug Elimination from Human Plasma; V. Genetic Conditions, Probably Transmitted as Single Factors, Altering the Way the Body Acts on Drugs; VI. Genetic Conditions, Probably Transmitted as Single Factors, Altering the Way Drugs Act on the Body; VII. Conclusion; References
|
505 |
8 |
|
|a Chapter 2. The Combination of Gas Chromatography and Mass Spectrometry in the Identification of Drugs and MetabolitesI. Introduction; II. Principles of Combined Gas Chromatography-Mass Spectrometry (GC-MS); III. Applications of Combined Gas Chromatography-Mass Spectrometry (GS-MS); IV. Conclusions; References; Chapter 3. Drugs and the Mechanism of Insulin Secretion; I. Introduction; II. Glucose, Hexoses, and Pentitols; III. Fatty Acids and Ketone Bodies; IV. Enteroinsular Axis; V. Amino Acids; VI. Glucagon; VII. Tolbutamide; VIII. Other Hormones; IX. Pharmacologic Agents
|
505 |
8 |
|
|a X. Insulin Synthesis and StorageXI. Cations; XII. Cyclic 3',5 '-AMP; XIII. �-Cell Secretion Hypothesis; References; Chapter 4. Antineoplastic Principles in Plants: Recent Developments in the Field; I. Introduction; II. Scope of the Present Report; III. Classes of Active Agents; IV. Plants Showing Antitumor Activity but no Longer of Interest; V. Conclusions; References; Chapter 5. The Evaluation of Present Antileprosy Compounds; I. Introduction; II. Experimental Evaluation of Drugs; III. Controlled Clinical Trials; IV. Modern Standard Therapy; V. Relapse in Leprosy; VI. Drug Resistance
|
505 |
8 |
|
|a VII. Drugs Used in Acute Exacerbation of Lepromatous LeprosyVIII. Prophylaxis; IX. The Way Ahead; References; Chapter 6. Chemotherapy of Chlamydial Infections; I. Introduction : Biological Characteristics of Chlamydiae-Types of Clinical Disease; II. Action of Antimicrobial Drugs on Chlamydiae in Experimental Models; III. Psittacosis and Ornithosis: Natural Infection in Birds; IV. Psittacosis in Man; V. Lymphogranuloma Venereum (LGV); VI. Trachoma-Inclusion Conjunctivitis (TRIC); VII. Summary; References; Chapter 7. Composition of Bacterial Cell Walls in Relation to Antibiotic Action
|
505 |
8 |
|
|a I. IntroductionII. Murein Biosynthesis; III. Connection between Antibiotic Action and Murein Synthesis; IV. Antibiotic Action and Murein Breakdown; V. Conclusion; References; Chapter 8. Advances in the Chemotherapy of Viral Diseases; I. Introduction; II. The Current Status of the Chemotherapy of Viral Diseases; III. The Reasons for the Limited Progress Made to Date and Suggestions for Improved Approaches; IV. The Future of the Chemotherapy of Viral Diseases; V. Conclusions; References; Chapter 9. A Pharmacological Analysis of Aspirin; I. Introduction; II. Antipyresis; III. Antinociception
|
520 |
|
|
|a ADV IN PHARMACOLOGY & CHEMOTHERAPY VOL 7.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Chemotherapy.
|
650 |
|
2 |
|a Pharmacology
|0 (DNLM)D010600
|
650 |
|
2 |
|a Drug Therapy
|0 (DNLM)D004358
|
650 |
|
6 |
|a Pharmacologie.
|0 (CaQQLa)201-0007219
|
650 |
|
6 |
|a Chimioth�erapie.
|0 (CaQQLa)201-0034750
|
650 |
|
7 |
|a pharmacology.
|2 aat
|0 (CStmoGRI)aat300137970
|
650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Chemotherapy
|2 fast
|0 (OCoLC)fst00853595
|
650 |
|
7 |
|a Pharmacology
|2 fast
|0 (OCoLC)fst01060259
|
700 |
1 |
|
|a Garattini, Silvio.
|
776 |
0 |
8 |
|i Print version:
|t Advances in pharmacology and chemotherapy. Volume 7.
|d New York : Academic Press, �1969
|z 9780120329076
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780120329076
|z Texto completo
|